Related Experiment Videos
Interleukin-4 receptor signaling pathways in asthma pathogenesis.
1Department of Pediatrics, The David Geffen School of Medicine at the University of California at Los Angeles, 10833 Le Conte Avenue, Los Angeles, CA 90095-1752, USA. Tchatila@mednet.ucla.edu
Trends in Molecular Medicine
|October 7, 2004
Summary
Interleukin-4 (IL-4) and IL-13 signaling pathways are crucial in asthma development. Genetic variations in these pathways influence asthma susceptibility and disease progression.
Area of Science:
- Immunology
- Allergy Research
- Genetic Epidemiology
Background:
- Asthma is a chronic allergic inflammatory disease.
- Interleukin-4 (IL-4) and IL-13 cytokines are key drivers of asthma pathogenesis.
- These cytokines signal through receptor complexes involving the IL-4 receptor alpha chain (IL-4Ralpha).
Purpose of the Study:
- To investigate the role of IL-4Ralpha-coupled signaling pathways in asthma.
- To explore the impact of genetic variations in the IL-4 and IL-13 cytokine-receptor axes on asthma.
- To understand how these pathways regulate early and chronic asthma stages.
Main Methods:
- Genetic approaches were utilized to study IL-4Ralpha signaling.
- Analysis of polymorphisms in cytokine-receptor axes components.
- Examination of pathway functions in asthma pathogenesis.
Main Results:
- Distinct functions of IL-4Ralpha-coupled signaling pathways in early and chronic asthma were identified.
- Polymorphisms in IL-4 and IL-13 axes are associated with allergy and asthma.
- Individual variations in pathway activity correlate with disease susceptibility and manifestations.
Conclusions:
- IL-4 and IL-13 signaling pathways are critical for asthma initiation and progression.
- Genetic variations within these pathways contribute significantly to asthma susceptibility and clinical presentation.
- Targeting these pathways may offer therapeutic strategies for asthma management.